Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,130 | 27 | 58.8% |
| Travel and Lodging | $792.25 | 4 | 41.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,559 | 19 | $0 (2024) |
| Boston Scientific Corporation | $211.01 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $31.56 | 2 | $0 (2018) |
| Flexion Therapeutics, Inc. | $28.60 | 1 | $0 (2019) |
| Medtronic, Inc. | $23.98 | 1 | $0 (2023) |
| SI-BONE, INC. | $19.64 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $15.85 | 1 | $0 (2018) |
| Purdue Pharma L.P. | $13.86 | 1 | $0 (2017) |
| Vertos Medical, Inc. | $11.05 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $90.73 | 5 | Abbott Laboratories ($54.06) |
| 2023 | $112.20 | 6 | Abbott Laboratories ($88.22) |
| 2019 | $1,345 | 10 | Abbott Laboratories ($1,208) |
| 2018 | $205.16 | 6 | Abbott Laboratories ($158.65) |
| 2017 | $168.74 | 4 | BOSTON SCIENTIFIC CORPORATION ($85.81) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Neuromodulation | ||||||
| 10/08/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Neuromodulation | ||||||
| 08/27/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $19.64 | General |
| 05/30/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Neuromodulation | ||||||
| 03/05/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/29/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Neuromodulation | ||||||
| 09/13/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Neuromodulation | ||||||
| 08/04/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Neuromodulation | ||||||
| 05/18/2023 | Abbott Laboratories | PENTA (Device) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Neuromodulation | ||||||
| 03/16/2023 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/09/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Neuromodulation | ||||||
| 11/15/2019 | Abbott Laboratories | S-Series SCS Leads (Device) | Food and Beverage | In-kind items and services | $132.89 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/14/2019 | Boston Scientific Corporation | SPECTRA WAVEWRITER (Device) | Food and Beverage | In-kind items and services | $108.17 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/14/2019 | Abbott Laboratories | SlimTip lead DRG Lead (Device) | Food and Beverage | In-kind items and services | $107.61 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 06/14/2019 | Abbott Laboratories | SlimTip lead DRG Lead (Device) | Food and Beverage | In-kind items and services | $73.66 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 05/23/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Travel and Lodging | Cash or cash equivalent | $19.15 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 05/11/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Travel and Lodging | In-kind items and services | $366.52 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 05/11/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $101.80 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 04/24/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Travel and Lodging | Cash or cash equivalent | $398.59 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 04/24/2019 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $7.99 | General |
| 02/20/2019 | Flexion Therapeutics, Inc. | Zilretta (Drug) | Food and Beverage | Cash or cash equivalent | $28.60 | General |
| Category: Musculoskeletal | ||||||
| 08/28/2018 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | Cash or cash equivalent | $11.05 | General |
| Category: Orthopedic | ||||||
| 05/23/2018 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $121.43 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 04/05/2018 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $37.22 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 04/03/2018 | AstraZeneca Pharmaceuticals LP | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 823 | 1,347 | $299,264 | $97,743 |
| 2022 | 13 | 643 | 1,133 | $221,771 | $75,952 |
| 2021 | 12 | 557 | 869 | $183,138 | $67,890 |
| 2020 | 16 | 565 | 818 | $185,497 | $63,933 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 428 | $79,180 | $37,513 | 47.4% |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 2023 | 176 | 282 | $54,144 | $16,143 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 105 | 105 | $28,875 | $12,007 | 41.6% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 92 | 135 | $27,000 | $9,582 | 35.5% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 33 | 47 | $27,450 | $4,106 | 15.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 17 | 26 | $12,600 | $3,546 | 28.1% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 26 | 77 | $9,779 | $3,246 | 33.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 24 | 36 | $12,000 | $3,098 | 25.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 30 | 34 | $26,875 | $2,436 | 9.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 23 | 35 | $7,250 | $1,820 | 25.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 21 | 32 | $7,626 | $1,717 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 17 | $2,125 | $1,048 | 49.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 15 | 23 | $2,760 | $1,007 | 36.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 23 | 50 | $500.00 | $284.10 | 56.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 13 | 20 | $1,100 | $191.60 | 17.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 244 | 450 | $83,250 | $37,720 | 45.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2022 | 102 | 160 | $32,000 | $10,995 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 95 | 95 | $26,125 | $9,894 | 37.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 35 | 64 | $14,694 | $3,366 | 22.9% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2022 | 11 | 16 | $7,650 | $2,463 | 32.2% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 25 | 56 | $7,112 | $2,315 | 32.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2022 | 16 | 26 | $8,000 | $2,299 | 28.7% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 25 | 29 | $24,375 | $2,122 | 8.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 34 | $4,250 | $2,108 | 49.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 12 | 16 | $8,550 | $1,428 | 16.7% |
About Dr. Scott Berry, M.D
Dr. Scott Berry, M.D is a Pain Medicine healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2010. The National Provider Identifier (NPI) number assigned to this provider is 1295050748.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Berry, M.D has received a total of $1,922 in payments from pharmaceutical and medical device companies, with $90.73 received in 2024. These payments were reported across 31 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,130).
As a Medicare-enrolled provider, Berry has provided services to 2,588 Medicare beneficiaries, totaling 4,167 services with total Medicare billing of $305,518. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location Latrobe, PA
- Active Since 03/27/2010
- Last Updated 09/11/2018
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1295050748
Products in Payments
- Proclaim Family of SCS IPGs (Device) $923.28
- SlimTip lead DRG Lead (Device) $181.27
- S-Series SCS Leads (Device) $132.89
- Octrode SCS Leads (Device) $121.43
- SPECTRA WAVEWRITER (Device) $108.17
- CLINICAL TRIAL PRODUCT (Device) $85.81
- OCTRODE (Device) $54.06
- DRG IPGs (Device) $50.34
- PROCLAIM (Device) $39.91
- Morphabond ER (Drug) $31.56
- Zilretta (Drug) $28.60
- ETERNA (Device) $24.75
- INTELLIS ADAPTIVESTIM (Device) $23.98
- PENTA (Device) $23.56
- MOVANTIK (Drug) $15.85
- OXYCONTIN (Drug) $13.86
- mild Device Kit (Device) $11.05
- Algovita (Device) $6.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.